MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 15.03.2024
Brickell Biotech ROCE 2011-2025 | BBI
ROCE Jährlich Brickell Biotech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -64.05 | -299.33 | -161.58 | -76.89 | -319.97 | -40.29 | -21.05 | -20.33 | -20.55 | -31.5 | -50.0 | -25.82 | -12.55 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -12.55 | -319.97 | -87.99 |
ROCE Vierteljährlich Brickell Biotech
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -109.48 | -181.86 | -161.6 | -122.08 | -188.98 | -201.75 | -244.22 | -149.59 | -165.62 | -114.75 | -81.84 | -50.03 | -193.16 | -257.08 | -277.52 | -323.05 | -174.89 | -91.74 | -59.2 | 3.01 | -7.02 | -15.24 | -13.81 | -14.95 | -20.65 | -21.34 | -18.9 | -14.18 | -14.92 | -9.95 | -13.18 | -15.38 | -23.85 | -31.58 | -33.26 | -23.0 | -39.25 | -47.04 | -55.24 | -47.43 | -56.17 | -48.65 | -41.53 | -17.8 | 9.36 | 45.26 | 40.16 | -1.29 | 27.16 | -14.0 | -14.44 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 45.26 | -323.05 | -72.5 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M |  USA |
 |
Alpine Immune Sciences
ALPN
|
-32.41 | - | - | $ 2.17 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
-73.67 | $ 4.67 | - | $ 775 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
-91.24 | $ 3.36 | - | $ 260 M | USA |
 |
AlloVir
ALVR
|
-57.76 | - | 4.14 % | $ 49.1 M | USA |
 |
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-353.66 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-40.28 | - | - | $ 1.01 B | USA |
 |
Ascendis Pharma A/S
ASND
|
-45.89 | $ 210.16 | - | $ 5 B |  Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | USA |
 |
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | USA |
 |
AstraZeneca PLC
AZN
|
11.12 | $ 90.29 | - | $ 96.9 B | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M |  Israel |
 |
Alterity Therapeutics Limited
ATHE
|
-104.38 | $ 3.42 | - | $ 8.23 B |  Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
28.05 | $ 25.9 | - | $ 1.25 B | USA |
 |
Anika Therapeutics
ANIK
|
-41.29 | $ 9.49 | - | $ 139 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-15.33 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
-1339.01 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
-69.03 | - | -7.31 % | $ 87 M | USA |
 |
Aytu BioScience
AYTU
|
-12.81 | $ 2.28 | - | $ 14.3 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-92.73 | - | -6.81 % | $ 3.04 B | USA |
 |
Biogen
BIIB
|
31.45 | $ 172.5 | - | $ 25.1 B | USA |
 |
Baudax Bio
BXRX
|
234.36 | - | 0.59 % | $ 63 K | USA |
 |
Avenue Therapeutics
ATXI
|
-403.4 | - | -52.27 % | $ 4.45 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - |  Russia |
 |
ChromaDex Corporation
CDXC
|
16.76 | - | -0.88 % | $ 598 M | USA |
 |
Axon Enterprise
AXON
|
2.51 | $ 581.03 | - | $ 44 B | USA |
 |
Checkpoint Therapeutics
CKPT
|
444.94 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
-75.78 | - | -16.75 % | $ 25.8 M | USA |
 |
Clovis Oncology
CLVS
|
80.97 | - | -7.23 % | $ 13 M | USA |
 |
BioVie
BIVI
|
-95.03 | $ 1.51 | -4.43 % | $ 2.23 M | USA |
 |
Cortexyme
CRTX
|
-40.69 | - | -1.05 % | $ 67.1 M | USA |
 |
Benitec Biopharma
BNTC
|
-10.11 | $ 12.96 | 1.17 % | $ 533 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-60.12 | - | - | $ 2.18 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
95.22 | $ 11.44 | - | $ 740 M | USA |
 |
BioNTech SE
BNTX
|
-4.81 | $ 96.0 | - | $ 27.2 B |  Germany |
 |
Eloxx Pharmaceuticals
ELOX
|
322.88 | - | -5.68 % | $ 8.28 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-115.03 | $ 0.29 | -0.31 % | $ 631 M | Israel |
 |
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | USA |
 |
Catalyst Biosciences
CBIO
|
424.75 | $ 15.31 | - | $ 1.01 B | USA |
 |
Enochian Biosciences
ENOB
|
903.05 | - | - | $ 40.5 M | USA |
 |
Epizyme
EPZM
|
1150.39 | - | - | $ 249 M | USA |
 |
Cerus Corporation
CERS
|
-25.34 | $ 2.15 | - | $ 397 M | USA |
 |
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K | USA |
 |
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | USA |
 |
Burford Capital Limited
BUR
|
14.24 | $ 9.14 | - | $ 1.5 B | Britain |